Pain Blocks for Open Abdominal Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine which pain block method is more effective for individuals undergoing open upper abdominal surgery. Researchers are comparing two pain management blocks: the External Oblique Intercostal Fascial Plane Block and the Oblique Subcostal Transversus Abdominis Plane Block. The trial targets patients scheduled for surgeries like gastrectomy or hepatectomy, who anticipate needing strong pain relief, such as opioids, for at least 48 hours post-surgery. Participants should not have severe liver or kidney conditions or be scheduled for certain other types of surgeries. As an unphased trial, this study allows patients to contribute to medical knowledge and potentially enhance pain management techniques for future surgeries.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that both the External Oblique Intercostal Fascial Plane (EOIFP) block and the Oblique Subcostal Transversus Abdominis Plane (OSTAP) block are generally safe and effective for managing pain during surgeries.
Studies have found that the EOIFP block reduces the need for opioids and decreases pain after surgery, particularly in patients with obesity. This approach manages pain effectively without over-relying on medications that might have more side effects.
For the OSTAP block, research indicates it provides excellent pain relief after surgeries like stomach surgery and minimally invasive procedures. It also effectively relieves pain after open umbilical hernia repair. Ultrasound guidance enhances the procedure's precision and safety.
Both treatments use a combination of liposomal bupivacaine and bupivacaine, well-known anesthetics commonly used in medical settings, adding an extra layer of safety. Overall, evidence supports that both blocks are safe and effective for managing pain in abdominal surgeries.12345Why are researchers excited about this trial?
Researchers are excited about these treatments because they offer new ways to manage pain after open abdominal surgery. Unlike traditional pain management options like opioids, which can have significant side effects, both the External Oblique Intercostal Fascial Plane Block and the Oblique Subcostal Transversus Abdominis Plane Block use ultrasound guidance to deliver a mix of liposomal bupivacaine and bupivacaine 0.25% directly to specific fascial planes. This targeted delivery method not only aims to reduce pain more effectively but also minimizes the need for systemic pain medication, potentially leading to fewer side effects and a quicker recovery. By focusing on these precise injection techniques, researchers hope to improve postoperative pain control significantly.
What evidence suggests that this trial's treatments could be effective for open abdominal surgery?
This trial will compare the effectiveness of two pain management techniques for open abdominal surgery. Research has shown that the Oblique Subcostal Transversus Abdominis Plane (OSTAP) block, one of the treatments participants may receive, effectively reduces pain after surgeries like stomach and liver operations. Studies have found it provides significant pain relief after abdominal surgeries. Meanwhile, the External Oblique Intercostal Fascial Plane (EOIFP) block, another treatment option in this trial, has helped with early recovery and reduced pain after surgery. One study even found it to be better than the OSTAP block for pain relief in upper abdominal surgeries. Both blocks numb the nerves in the abdominal area to reduce post-surgery pain, making them promising options for those undergoing abdominal surgery.24678
Who Is on the Research Team?
Ehab Farag, MD
Principal Investigator
The Cleveland Clinic
Are You a Good Fit for This Trial?
This trial is for patients who are scheduled for open upper abdominal surgery. Specific eligibility criteria were not provided, so it's important to contact the study organizers for detailed information on who can participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the EOIFP block or the OSTAP block under ultrasound guidance during their upper abdominal surgery
Postoperative Monitoring
Participants are monitored postoperatively for pain management and recovery, with adjustments to analgesic management as necessary
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- External Oblique Intercostal Fascial Plane Block
- Oblique Subcostal Transversus Abdominis Plane Block
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Cleveland Clinic
Lead Sponsor